Marshall Edwards Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Lorus Therapeutics Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Ligand Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Kyowa Hakko Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Kosan Biosciences Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Kirin Brewery Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

ViRexx Medical Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Keryx Biopharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Medigene Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Medimmune Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

ONCOGENEX TECHNOLOGIES Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Vical Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Novacea Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Neopharm Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Nemod Immunotherapie Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Millennium Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005